IDENTIFICATION AND EXPRESSION ANALYSIS OF ABC GENES IN PLASMODIUM YOELII

约氏疟原虫ABC基因的鉴定及表达分析

• 批准号: 7720857
• 负责人: IVAN FERRER
• 金额: $ 20.46万
• 依托单位: UNIVERSITY OF PUERTO RICO
• 依托单位国家: 美国
• 财政年份: 2008
• 资助国家: 美国
• 起止时间: 2008-08-01 至 2009-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7720857
• 关键词: Address; Anopheles gambiae; Anti-malarial drug resistance; Antimalarials; Binding; Bioinformatics; Carrier Proteins; Collection; Computer Retrieval of Information on Scientific Projects Database; Disruption; Drug Design; Drug resistance; Drug-sensitive; Evolution; Facility Construction Funding Category; Funding; Gene Dosage; Gene Proteins; Genes; Genome; Goals; Grant; Health; Homologous Gene; Institution; Lead; Location; Malaria; Measures; Mediating; Membrane; Modeling; Molecular; Multi-Drug Resistance; Multidrug Resistance-Associated Proteins; Numbers; Orthologous Gene; Parasites; Parasitic Diseases; Pharmaceutical Preparations; Plasmodium; Plasmodium yoelii; Proteins; Recombinant Proteins; Research; Research Personnel; Resistance; Resources; Rodent; Role; Single Nucleotide Polymorphism; Source; Transcript; Transfection; United States National Institutes of Health; Work; base; disorder control; in vivo; innovation; member; novel; quinoline; resistance mechanism

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Malaria is one of the most important parasitic diseases worldwide. The evolution and spread of multidrug resistant strains of P. falciparum and P. vivax is a major health concern. Despite the advances in research, including the sequencing of the entire genomes of Anopheles gambiae, P. falciparum and P. yoelii, the molecular basis of the drug resistance phenomena in Plasmodia is not completely understood. The long-term goal of the proposed research is to elucidate mechanisms by which the malaria parasites become resistant to antimalarial drugs. The results of this research could lead to a better approach to drug design and disease control. Our working hypothesis is that several genes that belong to the ATP-binding cassette (ABC) superfamily of transporter proteins work in conjunction to confer drug resistance. A collection of drug sensitive and resistant lines of P. yoelii will be used as an in vivo rodent malaria model to investigate the mechanisms of drug resistance. Although a number of resistance mechanisms are possible, we will focus on two members of the ABC superfamily of transporter proteins that may mediate drug efftux in the parasite, the multidrug resistance associated protein gene (pymrp) and the ABCG homologue gene. The specific aims are: - To characterize the P. yoelii multidrug resistance associated protein gene (pymrp) and to determine its role in malaria drug resistance. - To measure transcript levels of the pymrp gene in drug sensitive and resistant lines. - To determine the sub-cellular location and measure expression levels of the pyMRP protein. - To initiate transfection studies to address the function of the pyMRP protein by gene disruption. - To characterize a novel ABC gene, the P. yoelii ABCG homologue, and determine its role in malaria drug resistance. - To determine membrane topology and identify conserved motifs in the P. yoelii ABCG homologue by performing bioinformatic analyses. - To analyze the P. yoelii ABCG homologue, from drug sensitive and resistant lines, for gene copy number, single nucleotide polymorphisms (SNP), transcript levels and chromosomal location. - To determine the sub-cellular location and measure expression levels of the P. yoelii ABCG protein. The rational for this research is that understanding the role of pymrp and the P. yoelii ABCG homologue gene in Plasmodium drug resistance could provide the basis for better drug design and potentially lead to reversal of drug resistance to the quinoline-containing antimalarial drugs. This is an innovative research because the function of the Plasmodium mrp and ABCG ortholog genes and their potential role in drug resistance remains to be elucidated. During the first year we expect to accomplish the following goals: 1) To measure transcript levels of the pymrp gene in drug sensitive and resistant lines; 2) To determine membrane topology and identify conserved motifs in the P. yoelii ABCG homologue by performing bioinformatic analyses; and 3) To initiate the construction of the pyMRP recombinant protein.

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目和 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 疟疾是世界上最重要的寄生虫病之一。恶性疟原虫和间日疟原虫的多药耐药菌株的进化和传播是一个主要的健康问题。尽管研究取得了进展，包括对冈比亚按蚊、恶性疟原虫和约氏疟原虫的整个基因组进行了测序，但疟原虫抗药性现象的分子基础尚未完全了解。这项研究的长期目标是阐明疟原虫对抗疟药物产生耐药性的机制。这项研究的结果可能会为药物设计和疾病控制带来更好的方法。我们的工作假设是，属于ATP结合盒（ABC）转运蛋白超家族的几个基因协同工作，赋予耐药性。约氏疟原虫的药物敏感和耐药株系的集合将被用作体内啮齿动物疟疾模型以研究药物耐药性的机制。虽然一些耐药机制是可能的，我们将集中在ABC超家族的转运蛋白，可能介导药物efftux在寄生虫，多药耐药相关蛋白基因（pymrp）和ABCG同源基因的两个成员。 具体目标是： - 目的研究约氏疟原虫多药耐药相关蛋白基因（pymrp）的特性，探讨其在疟疾耐药中的作用。 - 测定pymrp基因在药物敏感和耐药株系中的转录水平。 - 确定pyMRP的亚细胞位置并测量其表达水平 蛋白 - 启动转染研究，以通过基因破坏解决pyMRP蛋白的功能。 - 描述一个新的ABC基因，约氏疟原虫ABCG同源基因，并确定其在疟疾耐药性中的作用。 - 通过生物信息学分析确定约氏疟原虫ABCG同源物的膜拓扑结构并鉴定其保守基序。 - 分析约氏疟原虫ABCG同源基因的基因拷贝数、单核苷酸多态性（SNP）、转录水平和染色体定位。 - 确定约氏疟原虫ABCG蛋白的亚细胞定位并测量其表达水平。 这项研究的理由是，了解pymrp和约氏疟原虫ABCG同源基因在疟原虫耐药性中的作用，可以为更好的药物设计提供基础，并可能导致逆转对含喹啉的抗疟药物的耐药性。这是一项创新性研究，因为疟原虫mrp和ABCG直系同源基因的功能及其在耐药性中的潜在作用仍有待阐明。在第一年期间，我们期望实现以下目标：1）测量药物敏感和抗性品系中pymrp基因的转录水平; 2）通过进行生物信息学分析来确定膜拓扑结构并鉴定约氏疟原虫ABCG同源物中的保守基序;以及3）启动pyMRP重组蛋白的构建。